The peroxisome-proliferator-activated receptor α agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E

Biochemical Journal

Volumn 373, Issue 3, 2003, Pages 941-947

  Fu, Tao ^a   Kashireddy, Papreddy ^a   Borensztajn, Jayme ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cholesterol; Fibrate; Lipoprotein remnant; Scavenger receptor BI; Triacylglycerol

Indexed keywords

CHOLESTEROL; FATTY ACIDS; OXIDATION; PROTEINS; RNA;

PLASMA CHOLESTEROL;

BIOCHEMISTRY;

ACYL COENZYME A DEHYDROGENASE; APOLIPOPROTEIN B48; APOLIPOPROTEIN E; BEZAFIBRATE; CHOLESTEROL; CIPROFIBRATE; FENOFIBRATE; LIVER ENZYME; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIRINIXIC ACID; TYLOXAPOL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; CHOLESTEROL BLOOD LEVEL; COMPARATIVE TOXICOLOGY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE EXACERBATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; FATTY ACID OXIDATION; FEMALE; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PEROXISOME; PRIORITY JOURNAL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOLIPOPROTEINS; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CLOFIBRIC ACID; FEMALE; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0042568979     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20030105     Document Type: Article

References (25)

1. Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E. and Fruchart, J. C. (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088-2093
2. Fruchart, J. C., Duriez, P. and Staels, B. (1999) Peroxisome proliferator-activated receptor-α activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis. Curr. Opin. Lipidol. 10, 245-257
3. Barbier, O., Torra, I. P., Duguay, Y., Blanquart, C., Fruchart, J. C., Glineur, C. and Staels, B. (2002) Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22, 717-726
4. Maeda, N., Li, H., Lee, D., Oliver, P., Quarfordt, S. H. and Osada, J. (1994) Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269, 23610-23616
5. Jong, M. C., Rensen, P. C., Dahlmans, V. E., van der Boom, H., van Berkel, T. J. and Havekes, L. M. (2001) Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice. J. Lipid Res. 42, 1578-1585
6. Zhang, S. H., Reddick, R. L., Piedrahita, J. A. and Maeda, N. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471
7. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M. and Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell (Cambridge, Mass.) 71, 343-353
8. Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L. and Ross, R. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14, 133-140
9. Fan, C. Y., Pan, J., Chu, R., Lee, D., Kluckman, K. D., Usuda, N., Singh, I., Yeldandi, A. V., Rao, M. S., Maeda, N. and Reddy, J. K. (1996) Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene. J. Biol. Chem. 271, 24698-24710
10. Hashimoto, T., Fujita, T., Usuda, N., Cook, W., Qi, C., Peters, J. M., Gonzalez, F. J., Yeldandi, A. V., Rao, M. S. and Reddy, J. K. (1999) Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J. Biol. Chem. 274, 19228-19236
11. Dwivedi, R. S., Alvares, K., Nemali, M. R., Subbarao, V., Reddy, M. K., Usman, M. I., Rademaker, A. W., Reddy, J. K. and Rao, M. S. (1989) Comparison of the peroxisome proliferator-induced pleiotropic response in the liver of nine strains of mice. Toxicol. Pathol. 17, 16-26
12. Borensztajn, J., Rone, M. S. and Kotlar, T. J. (1976) The inhibition in vivo of lipoprotein lipase (clearing-factor lipase) activity by Triton WR-1339. Biochem. J. 156, 539-543
13. Cherkaoui-Malki, M., Meyer, K., Cao, W. Q., Latruffe, N., Yeldandi, A. V., Rao, M. S., Bradfield, C. A. and Reddy, J. K. (2001) Identification of novel peroxisome prolilerator-activated receptor α (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene Expr. 9, 291-304
14. Mahley, R. W. and Ji, Z. S. (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J. Lipid Res. 40, 1-16
15. Reddick, R. L., Zhang, S. H. and Maeda, N. (1994) Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression. Arterioscler. Thromb. 14, 141-147
16. Cooper, A. D. (1997) Hepatic uptake of chylomicron remnants. J. Lipid Res. 38, 2173-2192
17. Havel, R. J. (1998) Receptor and non-receptor mediated uptake of chylomicron remnants by the liver. Atherosclerosis 141 (Suppl. 1), S1-S7
18. Mezdour, H., Jones, R., Dengremont, C., Castro, G. and Maeda, N. (1997) Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice. J. Biol. Chem. 272, 13570-13575
19. Bergeron, N., Kotite, L., Verges, M., Blanche, P., Hamilton, R. L., Krauss, R. M., Bensadoun, A. and Havel, R. J. (1998) Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. Proc. Natl. Acad. Sci. U.S.A. 95, 15647-15652
20. Bouly, M., Masson, D., Gross, B., Jiang, X. C., Fievet, C., Castro, G., Tall, A. R., Fruchart, J. C., Staels, B., Lagrost, L. et al. (2001) Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J. Biol. Chem. 276, 25841-25847
21. Schoonjans, K., Peinado-Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B. and Auwerx, J. (1998) PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J. 15, 5336-5348
22. Chang, S., Maeda, N. and Borensztajn, J. (1996) The role of lipoprotein lipase and apoprotein E in the recognition of chylomicrons and chylomicron remnants by cultured isolated mouse hepatocytes. Biochem. J. 318, 29-34
23. Crawford, S. E. and Borensztajn, J. (1999) Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway. J. Lipid Res. 40, 797-805
24. Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., Kozarsky, K. F., Altayo, M., Miquel, J. F., Luc, G. et al. (2003) Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J. Biol. Chem. 278, 7884-7890
25. Duez, H., Chao, Y. S., Hernandez, M., Torpier, G., Poulain, P., Mundt, S., Mallat, Z., Teissier, E., Burton, C. A., Tedgui, A. et al. (2002) Reduction of atherosclerosis by the peroxisome proliferator-activated receptor α agonist fenofibrate in mice. J. Biol. Chem. 277, 48051-48057